These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 33509743)
1. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47. Morka N; Simpson BS; Emberton M; Norris JM Eur Urol Oncol; 2021 Feb; 4(1):127-128. PubMed ID: 33509743 [No Abstract] [Full Text] [Related]
2. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41. Aning J; McCoubrie P; Oxley J Eur Urol; 2020 Nov; 78(5):e198-e199. PubMed ID: 32839000 [No Abstract] [Full Text] [Related]
3. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41. Gandaglia G; Montorsi F; Briganti A Eur Urol; 2020 Nov; 78(5):e200. PubMed ID: 32800726 [No Abstract] [Full Text] [Related]
4. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy. Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770 [TBL] [Abstract][Full Text] [Related]
5. Re: Alberto Martini, Giorgio Gandaglia, R. Jeffrey Karnes, et al. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. Eur Urol Oncol 2019;2:456-63. Giannarini G; Crestani A; Ficarra V Eur Urol Oncol; 2019 Jul; 2(4):472-473. PubMed ID: 31277786 [No Abstract] [Full Text] [Related]
6. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938 [TBL] [Abstract][Full Text] [Related]
7. Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303: The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all. Kasivisvanathan V; Takwoingi Y; Emberton M; Moore CM Eur Urol; 2019 Nov; 76(5):e133-e134. PubMed ID: 31400949 [No Abstract] [Full Text] [Related]
8. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019. Lei Y; Han S; Xing N Eur Urol; 2022 May; 81(5):e121. PubMed ID: 35125229 [No Abstract] [Full Text] [Related]
9. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019. Samaratunga H; Delahunt B; Egevad L Eur Urol; 2022 Jul; 82(1):e15-e16. PubMed ID: 35428506 [No Abstract] [Full Text] [Related]
10. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup. Marra G; Stabile A; Gontero P; Montorsi F; Briganti A; Gandaglia G; Eur Urol; 2022 May; 81(5):e115-e116. PubMed ID: 35151511 [No Abstract] [Full Text] [Related]
11. Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Radtke JP; Nyarangi-Dix J; Wiesenfarth M; Hadaschik B Eur Urol; 2021 Jan; 79(1):164-165. PubMed ID: 32847701 [No Abstract] [Full Text] [Related]
12. Reply to Roderick C.N. van den Bergh, Massimo Valerio, Derya Tilki, and Giorgio Gandaglia's Letter to the Editor re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2020.02.009. Wilt TJ; Dahm P; Brawer MK Eur Urol; 2020 Aug; 78(2):e69-e70. PubMed ID: 32303386 [No Abstract] [Full Text] [Related]
13. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. Alongi F; Aiello D; Mazzola R; Cavalleri S Eur Urol; 2017 Aug; 72(2):e39-e40. PubMed ID: 28318727 [No Abstract] [Full Text] [Related]
14. Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai's Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634. Giganti F; Dickinson L; Allen C; Moore CM Eur Urol Oncol; 2024 Apr; 7(2):308. PubMed ID: 37722978 [No Abstract] [Full Text] [Related]
15. Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes? Deniffel D; Salinas E; Ientilucci M; Evans AJ; Fleshner N; Ghai S; Hamilton R; Roberts A; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA; Perlis N J Urol; 2020 Dec; 204(6):1187-1194. PubMed ID: 32496160 [TBL] [Abstract][Full Text] [Related]
16. Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9. Achard V; Dal Pra A; Zilli T Eur Urol; 2020 Dec; 78(6):e221-e222. PubMed ID: 33008661 [No Abstract] [Full Text] [Related]
17. Re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72. Froehner M; Wirth MP Eur Urol; 2014 Nov; 66(5):e85. PubMed ID: 24867149 [No Abstract] [Full Text] [Related]
18. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7. Temiz MZ; Besiroglu H Eur Urol; 2018 May; 73(5):e130. PubMed ID: 29397220 [No Abstract] [Full Text] [Related]
19. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7. Dal Pra A; Supiot S; Ghadjar P Eur Urol; 2018 Feb; 73(2):e34-e35. PubMed ID: 28890243 [No Abstract] [Full Text] [Related]
20. Re: Giorgio Guazzoni, Massimo Lazzeri, Luciano Nava, et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol 2012;61:455-66. Tadtayev S; McNicholas TA; Boustead GB Eur Urol; 2012 Jul; 62(1):e14-5; author reply e16-7. PubMed ID: 22537798 [No Abstract] [Full Text] [Related] [Next] [New Search]